KARLSKOGA, Sweden, Nov. 11, 2025 /PRNewswire/ -- Last year, Cell Impact was awarded silver by EcoVadis. This year, the company has…
New RECMA Diagnostics Report Reveals OMD "Remains More than Ever the Leader" NEW YORK, Nov. 6, 2025 /PRNewswire/ -- In…
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible…
BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- With the growing emphasis on fitness and overall well-being, fitness enthusiasts do much…
Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients1 New findings from this investigational…
Basel, October 19, 2025 – Novartis today presents new Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan) data from the Phase III PSMAddition…
Mortara-Kvyat-Grosjean fight for overall victory in the 10-hour Road Atlanta marathonSant’Agata Bolognese/Braselton, GA, 12 October 2025 – The Lamborghini SC63…
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY,…
Expert jurors from 26 countries select Farizon SV for IVOTY shortlist High standards of efficiency and safety are key factors…
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy in this…